Russell Investments Group’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.17M | Sell |
26,700
-55,807
| -68% | -$2.44M | ﹤0.01% | 1993 |
|
|
2025
Q1 | $2.26M | Buy |
82,507
+23,584
| +40% | +$645K | ﹤0.01% | 1624 |
|
|
2024
Q4 | $2.37M | Sell |
58,923
-860
| -1% | -$34.6K | ﹤0.01% | 1589 |
|
|
2024
Q3 | $2.83M | Buy |
59,783
+6,350
| +12% | +$301K | ﹤0.01% | 1503 |
|
|
2024
Q2 | $1.59M | Buy |
53,433
+1,676
| +3% | +$50K | ﹤0.01% | 1750 |
|
|
2024
Q1 | $2.08M | Buy |
51,757
+2,646
| +5% | +$106K | ﹤0.01% | 1630 |
|
|
2023
Q4 | $1.25M | Buy |
49,111
+17,999
| +58% | +$458K | ﹤0.01% | 1857 |
|
|
2023
Q3 | $432K | Buy |
31,112
+12,945
| +71% | +$180K | ﹤0.01% | 2278 |
|
|
2023
Q2 | $418K | Sell |
18,167
-9,773
| -35% | -$225K | ﹤0.01% | 2272 |
|
|
2023
Q1 | $828K | Sell |
27,940
-979
| -3% | -$29K | ﹤0.01% | 2061 |
|
|
2022
Q4 | $722K | Buy |
28,919
+5,944
| +26% | +$148K | ﹤0.01% | 2134 |
|
|
2022
Q3 | $498K | Buy |
22,975
+2,650
| +13% | +$57.4K | ﹤0.01% | 2247 |
|
|
2022
Q2 | $398K | Buy |
+20,325
| New | +$398K | ﹤0.01% | 2338 |
|
|
2021
Q4 | – | Sell |
-3,699
| Closed | -$217K | – | 3052 |
|
|
2021
Q3 | $217K | Buy |
+3,699
| New | +$217K | ﹤0.01% | 2751 |
|
|
2021
Q2 | – | Sell |
-24,684
| Closed | -$951K | – | 3260 |
|
|
2021
Q1 | $951K | Buy |
24,684
+19,705
| +396% | +$759K | ﹤0.01% | 2265 |
|
|
2020
Q4 | $357K | Buy |
+4,979
| New | +$357K | ﹤0.01% | 2556 |
|